Everand Logo

Welcome to Everand!

  • STAT

    A Republican lobbying firm is behind Washington’s newest pro-pharma advocacy group

    A Republican lobbying firm helped set up a shadowy new pro-pharma group. Here are the latest details.
    by Nicholas Florko Oct 04, 2018 2 minutes

    WASHINGTON — A Republican lobbying firm, the CGCN Group, is behind this week’s launch of the shadowy drug pricing organization, Alliance to Protect Medical Innovation, a partner at the firm confirmed to STAT Thursday.

    It is still unclear who is funding the organization, but the group Thursday that it is joining as one of APMI’s first members.

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
    A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
    The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
    New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

    Related Books & Audiobooks